Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Neurol Sci. 2020 Nov;41(11):3149-3156. doi: 10.1007/s10072-020-04693-y. Epub 2020 Sep 2.
Similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), the coronavirus disease 2019 (COVID-19) has neurological symptoms. COVID-19 patients have such clinical symptoms as headache, vomiting, nausea, dizziness, myalgia, anosmia, ageusia, and disorder of consciousness. These symptoms confirm that the nervous system is involved in the COVID-19 infection. Guillain-Barré syndrome (GBS) is a heterogeneous disorder which often follows a viral infection. According to the assessment case reports from the beginning of the COVID-19 infection so far, it is possible that GBS is linked to the COVID-19 infection. It seems that paying attention to the neurological effects of COVID-19 is necessary.
与严重急性呼吸综合征冠状病毒（SARS-CoV）和中东呼吸综合征冠状病毒（MERS-CoV）类似，2019 冠状病毒病（COVID-19）有神经系统症状。COVID-19 患者有头痛、呕吐、恶心、头晕、肌痛、嗅觉丧失、味觉丧失和意识障碍等临床症状。这些症状证实神经系统参与了 COVID-19 感染。吉兰-巴雷综合征（GBS）是一种异质性疾病，常继发于病毒感染。根据迄今为止对 COVID-19 感染开始时的评估病例报告，GBS 可能与 COVID-19 感染有关。似乎有必要关注 COVID-19 的神经系统影响。
